Pharma-Bio Serv, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Pharma-Bio Serv, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q3 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending July 31, 2024 was $12.3M, a 17.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $12.3M -$2.56M -17.2% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $12.6M -$1.73M -12% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $12.9M -$2.83M -18.1% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $14.9M -$414K -2.71% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $14.9M -$193K -1.28% Jul 31, 2023 10-Q 2023-09-14
Q1 2023 $14.4M -$431K -2.91% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $15.7M -$596K -3.66% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $15.3M -$2.44M -13.8% Oct 31, 2022 10-K 2024-01-29
Q2 2022 $15.1M -$7.49M -33.2% Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $14.8M -$5.5M -27.1% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $16.3M -$3.77M -18.8% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $17.7M -$3.82M -17.7% Oct 31, 2021 10-K 2023-01-30
Q2 2021 $22.6M +$1.2M +5.62% Jul 31, 2021 10-Q 2021-09-14
Q1 2021 $20.3M -$383K -1.85% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 $20.1M +$64.7K +0.32% Jan 31, 2021 10-Q 2021-03-17
Q3 2020 $21.5M +$2.05M +10.5% Oct 31, 2020 10-K 2022-02-11
Q2 2020 $21.4M +$659K +3.18% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $20.7M +$398K +1.96% Apr 30, 2020 10-Q 2020-06-15
Q4 2019 $20M +$418K +2.13% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 $19.5M +$362K +1.89% Oct 31, 2019 10-K 2021-02-01
Q2 2019 $20.7M +$3.22M +18.4% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 $20.3M +$3.52M +21% Apr 30, 2019 10-Q 2019-06-14
Q4 2018 $19.6M +$2.69M +15.9% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 $19.1M -$449K -2.3% Oct 31, 2018 10-K 2020-01-29
Q2 2018 $17.5M -$2.61M -13% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 $16.8M -$3.5M -17.3% Apr 30, 2018 10-Q 2018-06-14
Q4 2017 $16.9M -$3.7M -18% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 $19.6M -$1.41M -6.75% Oct 31, 2017 10-K 2019-01-29
Q2 2017 $20.1M -$1.38M -6.43% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 $20.3M -$1.35M -6.24% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 $20.6M -$989K -4.58% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 $21M -$257K -1.21% Oct 31, 2016 10-K 2018-01-29
Q2 2016 $21.5M +$780K +3.77% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 $21.6M +$1.36M +6.74% Apr 30, 2016 10-Q 2016-06-14
Q4 2015 $21.6M +$1.69M +8.48% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 $21.2M +$1.62M +8.29% Oct 31, 2015 10-K 2017-01-31
Q2 2015 $20.7M +$1.93M +10.3% Jul 31, 2015 10-Q 2015-09-14
Q1 2015 $20.3M +$2.07M +11.4% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 $19.9M +$2.04M +11.4% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 $19.6M +$2.41M +14% Oct 31, 2014 10-K 2016-01-29
Q2 2014 $18.8M +$2.81M +17.6% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $18.2M +$3.46M +23.5% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 $17.9M +$4.52M +33.8% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $17.2M +$4.91M +39.9% Oct 31, 2013 10-K 2015-01-29
Q2 2013 $16M +$4.76M +42.5% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 $14.7M +$4.79M +48.2% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 $13.3M +$4.59M +52.5% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $12.3M +$4.69M +61.7% Oct 31, 2012 10-K 2014-01-29
Q2 2012 $11.2M +$4.43M +65.5% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 $9.93M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 $8.75M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 $7.6M +$3.16M +71.1% Oct 31, 2011 10-K 2013-01-29
Q2 2011 $6.78M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 $4.44M Oct 31, 2010 10-K/A 2012-01-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.